Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4794071
Max Phase: Preclinical
Molecular Formula: C28H38IN9O7
Molecular Weight: 739.57
Molecule Type: Unknown
Associated Items:
ID: ALA4794071
Max Phase: Preclinical
Molecular Formula: C28H38IN9O7
Molecular Weight: 739.57
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3c(I)cccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC1=O
Standard InChI: InChI=1S/C28H38IN9O7/c1-13(2)22-27(45)36-17(7-4-8-32-28(30)31)24(42)34-12-20(39)35-19(10-21(40)41)25(43)37-18(26(44)38-22)9-14-11-33-23-15(14)5-3-6-16(23)29/h3,5-6,11,13,17-19,22,33H,4,7-10,12H2,1-2H3,(H,34,42)(H,35,39)(H,36,45)(H,37,43)(H,38,44)(H,40,41)(H4,30,31,32)/t17-,18+,19-,22-/m0/s1
Standard InChI Key: RIRSYRXZEYNCLO-WEMPKCCASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 739.57 | Molecular Weight (Monoisotopic): 739.1939 | AlogP: -1.22 | #Rotatable Bonds: 9 |
Polar Surface Area: 260.49 | Molecular Species: ZWITTERION | HBA: 7 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.97 | CX Basic pKa: 11.90 | CX LogP: -2.88 | CX LogD: -2.88 |
Aromatic Rings: 2 | Heavy Atoms: 45 | QED Weighted: 0.06 | Np Likeness Score: 0.95 |
1. Kemker I,Schröder DC,Feiner RC,Müller KM,Marion A,Sewald N. (2021) Tuning the Biological Activity of RGD Peptides with Halotryptophans†., 64 (1.0): [PMID:33356253] [10.1021/acs.jmedchem.0c01536] |
Source(1):